Efficacy and Safety of Atorvastatin as Adjunctive Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Ke Chen, Bowen Xu, Lu Zhang, Li Fang, Di Wu, Huanzhang Ding, Zegeng Li
doi: https://doi.org/10.1101/2024.12.04.24318509

Article Information

doi 
https://doi.org/10.1101/2024.12.04.24318509
History 
  • December 6, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Ke Chen1,4,5,
  2. Bowen Xu1,4,5,
  3. Lu Zhang2,4,5,
  4. Li Fang1,4,5,
  5. Di Wu3,4,5,
  6. Huanzhang Ding1,4,5 and
  7. Zegeng Li1,2,4,5,*
  1. 1The First Clinical Medical College of Anhui University of Chinese Medicine, Hefei, 230031, China
  2. 2Anhui University of Chinese Medicine, Hefei,230012, China
  3. 3Anhui Provincial Chinese Medicine Hospital, Hefei, 230031, China
  4. 4Institute of Traditional Chinese Medicine for Respiratory Disease Prevention and Treatment, Anhui Academy of Traditional Chinese Medicine, Hefei, 230031
  5. 5Anhui Provincial Key Laboratory of Translational Medicine for Prevention and Treatment of Major Respiratory Diseases with Traditional Chinese Medicine, Hefei, 230031
  1. ↵*Corresponding Author: Zegeng Li email:15056765167{at}163.com, Anhui Provincial Chinese Medicine Hospital
Back to top
Posted December 06, 2024.
Download PDF
Data/Code
Email
Efficacy and Safety of Atorvastatin as Adjunctive Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Ke Chen, Bowen Xu, Lu Zhang, Li Fang, Di Wu, Huanzhang Ding, Zegeng Li
medRxiv 2024.12.04.24318509; doi: https://doi.org/10.1101/2024.12.04.24318509
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area